Kasra Eliasieh, MD
Ophthalmology · Berkeley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 3 carriers
- Offices
- 2
Offices
2 locations · Alameda Health System · 597 clinicians in this group
Hospitals listed: Highland Hospital. That is not proof they admit you there this week.
Plans that list them
13 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Eliasieh’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A132513 · Current
Licensed to practise in California · since 2014 · expires 2028-04-30 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- San Leandro Surgery Center, Ltd. dba San Leandro Surgery CenterAmbulatory Surgery Center · San Leandro, CA.5 owner since 2017 · accredited by AAAHCAccreditation Renewed2 inspections · last 2023-06-12
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Highland HospitalOakland, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Alameda Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.568, Oct 2024 – Sep 2025
See every measure and the patient survey for Highland Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 5 the same, 1 worse of 6 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.568 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 487 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.7 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.35 (145.43 to 251.26) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 83 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.3 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.9 · 237 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 68 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 1,143 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.38) · 4,370 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.07 to 0.47) · 4,344 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.54 (0.29 to 4.79) · 689 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.07 (0.37 to 3.78) · 165 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.91 (0.34 to 3.48) · 681 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.62 (2.72 to 20.53) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.44 (1.37 to 9.5) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.97 (0.49 to 3.45) · 126 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.76 (0.07 to 1.44) · 3,387 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.519 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.682 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 51 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 184 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 141.8 · 59 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 27.6 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 35.3 · 253 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 243 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.2 to 7.7) · 64 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (9.7 to 18.5) · 64 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.4 (10.8 to 19.4) · 355 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 84 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,960 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
Original Medicare doctor bills
$140,426
Medicare paid this office $140,426 for 272 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 128 | $17,850 | $139 |
| Removal of excessive skin and fat of upper eyelid | 14 | $11,067 | $790 |
| Short return visit (20+ min) | 83 | $8,786 | $79 |
| Removal of tissue, muscle, and membrane to correct eyelid drooping or paralysis | 17 | $8,047 | $473 |
| Return visit (30+ min) | 43 | $6,362 | $133 |
See all 13 services
| New patient visit (45+ min) | 128 | $17,850 | $139 |
| Removal of excessive skin and fat of upper eyelid | 14 | $11,067 | $790 |
| Short return visit (20+ min) | 83 | $8,786 | $79 |
| Removal of tissue, muscle, and membrane to correct eyelid drooping or paralysis | 17 | $8,047 | $473 |
| Return visit (30+ min) | 43 | $6,362 | $133 |
| Extensive repair of turning-outward eyelid defect | 14 | $5,998 | $353 |
| Botox | 11 | $4,660 | None |
| Insertion of probe into nasal tear duct | 18 | $4,636 | $258 |
| Probing of nasal tear duct | 22 | $3,572 | $137 |
| Removal of growth of eyelid | 12 | $3,532 | $294 |
| Face injection for nerve paralysis | 14 | $2,079 | $122 |
| Photography of content of eyes | 91 | $1,949 | $21 |
| Exam of visual field with extended testing | 23 | $1,278 | $56 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
Who their Medicare patients are
272 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 14% · Women 58% · Also on Medicaid 31% · Health risk score 1.18. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 65% · Diabetes 27% · Chronic kidney disease 23% · Coronary heart disease 21% · Atrial fibrillation 17% · COPD 13% · Depression 13% · Heart failure 12% · Cancer 11% · Stroke 5% · Dementia 4%.
The office billed $523,493, Medicare allowed $182,659 and paid $140,426; for 1,637 services of 54 kinds; $4,727 of it was for drugs given in the office and $135,699 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 272 | 1,637 | 75 | 1.18 | $523,493 | $140,426 |
| 2023 | 429 | 2,525 | 76 | 1.11 | $528,066 | $189,449 |
| 2022 | 421 | 2,148 | 75 | 1.00 | $597,772 | $192,699 |
| 2021 | 361 | 1,981 | 75 | 1.16 | $531,619 | $170,449 |
| 2020 | 304 | 1,435 | 74 | 1.11 | $739,568 | $148,313 |
| 2019 | 424 | 1,829 | 75 | 1.08 | $953,696 | $180,361 |
| 2018 | 355 | 1,372 | 75 | 1.29 | $799,451 | $156,607 |
| 2017 | 341 | 947 | 74 | 1.13 | $700,638 | $130,101 |
| 2016 | 354 | 760 | 75 | 1.18 | $532,833 | $111,821 |
| 2015 | 187 | 459 | 75 | 1.28 | $114,761 | $40,458 |
| 2014 | 56 | 176 | 71 | 1.57 | $28,584 | $9,497 |
| 2013 | 67 | 83 | 71 | 1.49 | $40,112 | $13,744 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Removal of excessive skin and fat of upper eyelid | 52 | $36,210 | $696 |
| Short return visit (20+ min) | 263 | $22,684 | $73 |
| New patient visit (45+ min) | 154 | $21,222 | $138 |
| Removal of tissue, muscle, and membrane to correct eyelid drooping or paralysis | 45 | $17,174 | $373 |
| Extensive repair of turning-inward eyelid defect | 21 | $10,092 | $481 |
| Repair of brow paralysis | 15 | $8,896 | $556 |
| Extensive repair of turning-outward eyelid defect | 23 | $8,346 | $334 |
| Botox | 12 | $6,982 | None |
| Removal of growth of eyelid | 23 | $6,388 | $266 |
| Photography of content of eyes | 197 | $4,099 | $20 |
| Probing of nasal tear duct | 29 | $4,024 | $134 |
| Face injection for nerve paralysis | 15 | $3,950 | $116 |
| New patient visit (30+ min) | 13 | $988 | $76 |
| Temporary closure of eyelids by suture | 11 | $537 | $49 |
2022: 14 services
| Removal of excessive skin and fat of upper eyelid | 73 | $48,575 | $665 |
| Short return visit (20+ min) | 242 | $21,826 | $70 |
| New patient visit (45+ min) | 147 | $20,982 | $143 |
| Removal of tissue, muscle, and membrane to correct eyelid drooping or paralysis | 52 | $19,346 | $352 |
| Repair of brow paralysis | 29 | $11,530 | $398 |
| Extensive repair of turning-inward eyelid defect | 21 | $8,903 | $387 |
| Removal of growth of eyelid | 30 | $8,262 | $236 |
| Extensive repair of turning-outward eyelid defect | 15 | $5,561 | $371 |
| Probing of nasal tear duct | 34 | $4,634 | $125 |
| Botox | 11 | $4,441 | None |
| Photography of content of eyes | 202 | $4,186 | $19 |
| Face injection for nerve paralysis | 11 | $3,220 | $115 |
| Probing of nasal tear duct with insertion of tube or stent | 12 | $1,360 | $113 |
| New patient visit (30+ min) | 15 | $1,218 | $81 |
2021: 14 services
| Removal of excessive skin and fat of upper eyelid | 56 | $37,830 | $676 |
| Short return visit (20+ min) | 206 | $18,191 | $71 |
| Removal of tissue, muscle, and membrane to correct eyelid drooping or paralysis | 43 | $16,354 | $372 |
| New patient visit (45+ min) | 103 | $14,659 | $142 |
| Repair of brow paralysis | 22 | $10,507 | $478 |
| Extensive repair of turning-inward eyelid defect | 20 | $8,875 | $403 |
| Removal of growth of eyelid | 19 | $5,302 | $265 |
| Botox | 11 | $4,497 | None |
| Face injection for nerve paralysis | 11 | $3,259 | $112 |
| Photography of content of eyes | 161 | $3,184 | $19 |
| Probing of nasal tear duct | 17 | $2,160 | $127 |
| New patient visit (30+ min) | 14 | $1,172 | $84 |
| Established patient problem focused exam of visual system | 18 | $1,067 | $40 |
| Short return visit | 11 | $618 | $52 |
2020: 10 services
| Removal of excessive skin and fat of upper eyelid | 59 | $40,930 | $694 |
| Removal of tissue, muscle, and membrane to correct eyelid drooping or paralysis | 54 | $19,272 | $357 |
| Repair of brow paralysis | 34 | $17,165 | $490 |
| Short return visit (20+ min) | 167 | $11,244 | $56 |
| New patient visit (45+ min) | 79 | $9,674 | $122 |
| Extensive repair of turning-inward eyelid defect | 14 | $6,399 | $427 |
| Removal of growth of eyelid | 11 | $2,666 | $242 |
| Return visit (30+ min) | 29 | $1,789 | $62 |
| Photography of content of eyes | 72 | $1,421 | $18 |
| Probing of nasal tear duct | 11 | $1,323 | $120 |
2019: 16 services
| Removal of excessive skin and fat of upper eyelid | 51 | $28,514 | $559 |
| New patient visit (45+ min) | 140 | $19,712 | $141 |
| Short return visit (20+ min) | 229 | $16,536 | $59 |
| Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | 18 | $14,111 | $706 |
| Repair of tendon of upper eyelid | 21 | $13,823 | $658 |
| Repair of brow paralysis | 39 | $13,756 | $353 |
| Removal of tissue, muscle, and membrane to correct eyelid drooping or paralysis | 31 | $10,128 | $327 |
| Removal of growth of eyelid | 22 | $6,050 | $263 |
| Extensive repair of turning-outward eyelid defect | 12 | $4,469 | $372 |
| Probing of nasal tear duct | 27 | $3,411 | $122 |
| Repair of turning-outward eyelid defect | 11 | $2,756 | $230 |
| Return visit (30+ min) | 34 | $2,605 | $77 |
| Photography of content of eyes | 104 | $2,008 | $18 |
| Exam of visual field with extended testing | 33 | $1,599 | $46 |
| Probing of nasal tear duct with insertion of tube or stent | 11 | $1,585 | $122 |
| Short return visit | 11 | $225 | $20 |
2018: 15 services
| Removal of excessive skin and fat of upper eyelid | 33 | $21,330 | $646 |
| New patient visit (45+ min) | 150 | $20,346 | $136 |
| Repair of tendon of upper eyelid | 16 | $12,460 | $692 |
| Repair of brow paralysis | 26 | $10,448 | $402 |
| Short return visit (20+ min) | 139 | $10,074 | $59 |
| Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | 11 | $9,548 | $734 |
| Removal of tissue, muscle, and membrane to correct eyelid drooping or paralysis | 21 | $9,202 | $418 |
| Extensive repair of turning-inward eyelid defect | 18 | $7,894 | $415 |
| Removal of growth of eyelid | 25 | $6,713 | $217 |
| Return visit (30+ min) | 74 | $6,254 | $83 |
| Extensive repair of turning-outward eyelid defect | 14 | $5,089 | $318 |
| Probing of nasal tear duct | 25 | $3,103 | $124 |
| Exam of visual field with extended testing | 42 | $2,291 | $53 |
| Probing of nasal tear duct with insertion of tube or stent | 11 | $2,020 | $135 |
| Photography of content of eyes | 109 | $2,010 | $18 |
2017: 12 services
| Removal of excessive skin and fat of upper eyelid | 48 | $31,670 | $660 |
| Repair of tendon of upper eyelid | 22 | $15,503 | $705 |
| New patient visit (45+ min) | 86 | $11,644 | $135 |
| Extensive repair of turning-inward eyelid defect | 18 | $7,991 | $421 |
| Short return visit (20+ min) | 118 | $7,086 | $53 |
| Exam of visual field with extended testing | 132 | $6,380 | $47 |
| Return visit (30+ min) | 88 | $6,182 | $69 |
| Repair of brow paralysis | 12 | $6,141 | $512 |
| Extensive repair of turning-outward eyelid defect | 11 | $3,249 | $271 |
| Removal of growth of eyelid | 12 | $2,793 | $199 |
| Probing of nasal tear duct | 15 | $1,837 | $115 |
| Photography of content of eyes | 80 | $1,431 | $18 |
2016: 12 services
| Removal of excessive skin and fat of upper eyelid | 28 | $17,589 | $628 |
| Short return visit (20+ min) | 179 | $12,893 | $56 |
| Shortening or advancement of upper eyelid muscle to correct drooping or paralysis | 16 | $8,629 | $539 |
| Repair of tendon of upper eyelid | 12 | $7,723 | $644 |
| Return visit (30+ min) | 80 | $6,818 | $84 |
| New patient visit (45+ min) | 36 | $4,821 | $134 |
| Exam of visual field with extended testing | 80 | $4,031 | $50 |
| Probing of nasal tear duct | 23 | $3,172 | $138 |
| New patient visit (30+ min) | 34 | $2,833 | $83 |
| Closure of tear duct opening using plug | 11 | $1,904 | $95 |
| Microfluid analysis of tears | 17 | $772 | $22 |
| Photography of content of eyes | 39 | $499 | $13 |
2015: 5 services
| Short return visit (20+ min) | 146 | $13,532 | $63 |
| Return visit (30+ min) | 25 | $2,355 | $94 |
| Microfluid analysis of tears | 39 | $1,806 | $22 |
| New patient visit (45+ min) | 12 | $1,769 | $147 |
| Exam of visual field with extended testing | 25 | $1,455 | $58 |
2014: 1 service
| Short return visit (20+ min) | 13 | $853 | $53 |
2013: 1 service
| Tying or biopsy of artery on side of skull | 13 | $2,551 | $182 |
Medicaid work
$11,440 in 2024
Medicaid paid $11,440 for 152 billed services this clinician did in 2024, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 56 | $7,677 |
| New patient visit (45+ min) | 60 | $2,433 |
| Short return visit (20+ min) | 12 | $557 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 12 | $460 |
| Return visit (30+ min) | 12 | $312 |
| 2024 | 152 | 5 | 23 | $11,440 |
| 2023 | 149 | 3 | 16 | $15,215 |
| 2022 | 138 | 3 | 19 | $13,667 |
| 2021 | 94 | 2 | 17 | $6,998 |
| 2020 | 29 | 1 | 16 | $3,557 |
| 2019 | 15 | 1 | 14 | $1,647 |
| 2018 | 26 | 1 | 13 | $2,209 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 83 | $11,108 |
| New patient visit (45+ min) | 54 | $3,149 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 12 | $959 |
2022
| Clinic visit/encounter, all-inclusive | 52 | $6,960 |
| New patient visit (45+ min) | 52 | $4,247 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 34 | $2,461 |
2021
| New patient visit (45+ min) | 82 | $6,998 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 12 | $0 |
2020
| New patient visit (45+ min) | 29 | $3,557 |
2019
| New patient visit (45+ min) | 15 | $1,647 |
2018
| New patient visit (45+ min) | 26 | $2,209 |
Drugs they prescribed that Part D paid
$397,928
Pharmacies billed $397,928 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
193 generic and 117 brand-name prescriptions · $397,928 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Neomycin-Polymyxin-Dexameth | 122 | $1,808 | $11 |
| Prednisolone Acetate | 12 | $638 | $43 |
| Erythromycin | 18 | $194 | $10 |
Year by year
| 2024 | 310 | 182 | None | 38% | $397,928 |
| 2023 | 718 | 313 | None | 37% | $135,234 |
| 2022 | 851 | 373 | None | 36% | $32,567 |
| 2021 | 650 | 286 | None | 32% | $34,792 |
| 2020 | 446 | 201 | None | 30% | $35,769 |
| 2019 | 571 | 245 | 2% (12) | 39% | $43,838 |
| 2018 | 468 | 227 | None | 31% | $30,427 |
| 2017 | 283 | 179 | 8% (23) | 34% | $12,336 |
| 2016 | 275 | 151 | 17% (47) | 40% | $19,259 |
| 2015 | 133 | 75 | None | 51% | $11,285 |
| 2014 | 122 | 67 | 21% (26) | 48% | $9,096 |
| 2013 | 269 | 131 | 24% (64) | 57% | $21,418 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Neomycin-Polymyxin-Dexameth | 329 | $4,568 | $14 |
| Prednisolone Acetate | 41 | $1,892 | $46 |
| Difluprednate | 11 | $1,316 | $120 |
| Dorzolamide-Timolol | 38 | $1,257 | $33 |
| Latanoprost | 62 | $1,121 | $18 |
| Moxifloxacin | 24 | $999 | $42 |
| Brimonidine | 30 | $960 | $32 |
| Erythromycin | 34 | $345 | $10 |
| Dorzolamide | 14 | $267 | $19 |
| Timolol Maleate | 18 | $257 | $14 |
2022: 11 drugs
| Lumigan | 16 | $5,631 | $352 |
| Neomycin-Polymyxin-Dexameth | 373 | $4,980 | $13 |
| Prednisolone Acetate | 59 | $3,097 | $52 |
| Simbrinza | 11 | $2,248 | $204 |
| Brimonidine | 28 | $1,830 | $65 |
| Dorzolamide-Timolol | 47 | $1,346 | $29 |
| Tobramycin-Dexamethasone | 11 | $1,056 | $96 |
| Latanoprost | 65 | $857 | $13 |
| Erythromycin | 80 | $830 | $10 |
| Dorzolamide | 18 | $737 | $41 |
| Timolol Maleate | 22 | $263 | $12 |
2021: 9 drugs
| Lumigan | 27 | $8,505 | $315 |
| Neomycin-Polymyxin-Dexameth | 180 | $2,732 | $15 |
| Prednisolone Acetate | 41 | $2,420 | $59 |
| Erythromycin | 150 | $1,782 | $12 |
| Dorzolamide-Timolol | 32 | $1,398 | $44 |
| Latanoprost | 51 | $639 | $13 |
| Timolol Maleate | 23 | $192 | $8 |
| Brimonidine | 13 | $179 | $14 |
| Ofloxacin | 12 | $156 | $13 |
2020: 12 drugs
| Rocklatan | 14 | $4,587 | $328 |
| Travatan Z | 11 | $3,663 | $333 |
| Lumigan | 12 | $3,596 | $300 |
| Durezol | 17 | $3,530 | $208 |
| Simbrinza | 13 | $3,417 | $263 |
| Erythromycin | 151 | $1,859 | $12 |
| Tobramycin-Dexamethasone | 12 | $1,234 | $103 |
| Dorzolamide-Timolol | 23 | $1,186 | $52 |
| Prednisolone Acetate | 15 | $925 | $62 |
| Neomycin-Polymyxin-Dexameth | 45 | $713 | $16 |
| Latanoprost | 24 | $370 | $15 |
| Timolol Maleate | 23 | $236 | $10 |
2019: 12 drugs
| Azopt | 12 | $6,764 | $564 |
| Lumigan | 14 | $5,572 | $398 |
| Travatan Z | 24 | $4,489 | $187 |
| Simbrinza | 11 | $2,995 | $272 |
| Neomycin-Polymyxin-Dexameth | 168 | $2,575 | $15 |
| Bacitracin | 25 | $2,311 | $92 |
| Tobramycin-Dexamethasone | 17 | $1,487 | $87 |
| Prednisolone Acetate | 23 | $1,167 | $51 |
| Dorzolamide-Timolol | 35 | $1,027 | $29 |
| Erythromycin | 70 | $863 | $12 |
| Latanoprost | 26 | $694 | $27 |
| Timolol Maleate | 38 | $234 | $6 |
2018: 11 drugs
| Azopt | 13 | $5,224 | $402 |
| Travatan Z | 23 | $4,531 | $197 |
| Tobradex | 13 | $2,934 | $226 |
| Tobramycin-Dexamethasone | 25 | $2,106 | $84 |
| Erythromycin | 179 | $1,831 | $10 |
| Prednisolone Acetate | 17 | $851 | $50 |
| Desonide | 12 | $768 | $64 |
| Neomycin-Polymyxin-Dexameth | 30 | $431 | $14 |
| Latanoprost | 23 | $307 | $13 |
| Dorzolamide-Timolol | 15 | $250 | $17 |
| Timolol Maleate | 22 | $151 | $7 |
2017: 6 drugs
| Tobradex | 18 | $3,867 | $215 |
| Neomycin-Polymyxin-Dexameth | 100 | $1,624 | $16 |
| Tobramycin-Dexamethasone | 12 | $953 | $79 |
| Erythromycin | 34 | $320 | $9 |
| Gentak | 18 | $267 | $15 |
| Hydrocodone-Acetaminophen | 20 | $81 | $4 |
2016: 6 drugs
| Restasis | 20 | $10,113 | $506 |
| Pazeo | 17 | $2,644 | $156 |
| Neomycin-Polymyxin-Dexameth | 139 | $2,415 | $17 |
| Pataday | 11 | $1,776 | $161 |
| Hydrocodone-Acetaminophen | 46 | $215 | $5 |
| Erythromycin | 11 | $127 | $12 |
2015: 3 drugs
| Restasis | 11 | $6,390 | $581 |
| Neomycin-Polymyxin-Dexameth | 78 | $1,440 | $18 |
| Erythromycin | 12 | $156 | $13 |
2014: 4 drugs
| Tobradex | 23 | $3,940 | $171 |
| Tobramycin-Dexamethasone | 29 | $2,648 | $91 |
| Neomycin-Polymyxin-Dexameth | 17 | $300 | $18 |
| Oxycodone-Acetaminophen | 23 | $96 | $4 |
2013: 3 drugs
| Tobradex | 54 | $9,029 | $167 |
| Tobramycin-Dexamethasone | 68 | $6,217 | $91 |
| Oxycodone-Acetaminophen | 60 | $207 | $3 |
Money from drug and device companies
$144 in 2025
| 2025 | 3 | 5 | None | $144 |
| 2024 | 1 | 4 | None | $70 |
| 2023 | 1 | 1 | None | $16 |
| 2022 | 2 | 2 | None | $45 |
| 2021 | 2 | 4 | None | $77 |
| 2020 | 1 | 2 | None | $32 |
| 2019 | 2 | 4 | None | $155 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Tepezza | $82 | 3 payments
|
| Merz Pharmaceuticals | Xeomin | $37 | 1 payment
|
| Abbvie | Durysta | $24 | 1 payment
|
See all 5 published payments
| Amgen | Meals · 2025-10-01 | Tepezza | $36 |
| Merz Pharmaceuticals | Meals · 2025-05-15 | Xeomin | $37 |
| Amgen | Meals · 2025-05-08 | Tepezza | $25 |
| Amgen | Meals · 2025-02-21 | Tepezza | $21 |
| Abbvie | Meals · 2025-02-05 | Durysta | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $70
| Amgen | Tepezza | $70 | 4 payments
|
2023: $16
| Horizon Therapeutics plc | Tepezza | $16 | 1 payment
|
2022: $45
| Horizon Therapeutics plc | Tepezza | $25 | 1 payment
|
| Rayner Intraocular Lenses | Omidria | $19 | 1 payment
|
2021: $77
| Omeros | Omidria | $52 | 3 payments
|
| Bausch & Lomb a division of Bausch Health US | Prolensa | $24 | 1 payment
|
2020: $32
| Omeros | Omidria | $32 | 2 payments
|
2019: $155
| Galderma Laboratories L.P. | None | $108 | 1 payment
|
| Omeros | Omidria | $48 | 3 payments
|
Checkups this office reported
7 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 99.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 65%That's more than half. | 362 |
| Breast cancer screeningEligible women who got a mammogram | 91%That's most of the people this applied to. | 181 |
| Checked for fall riskOlder patients screened for fall risk | 92%That's most of the people this applied to. | 315 |
| Medications listed in the chartVisits where the current medication list was documented | 100%That's most of the people this applied to. | 1,140 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 70%That's more than half. | 945 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 100%That's most of the people this applied to. | 425 |
| Support Electronic Referral Loops By Sending Health InformationAs Medicare defines this measure | 40% | 736 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Checks the state prescription-drug database before prescribing
- COVID-19 Vaccine Achievement for Practice Staff
- Did a security review of patient data
- Drug Cost Transparency
- High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides
- Implementation of a Personal Protective Equipment (PPE) Plan
- Implementation of Use of Specialist Reports Back to Referring Clinician or Group to Close Referral Loop
- Offers telehealth visits
- ONC-ACB Surveillance Attestation
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
- Provide Education Opportunities for New Clinicians
- Reports cases to public health electronically
- Reports to a public-health or clinical registry
- Exempt from immunization registry reporting
Professional record
- NPI
- 1194954677
- Licence
- CA A132513California A132513: Current · expires 2028-04-30
- Trained
- University of California, Davis School of Medicine, 2008
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- MD 055392100
- Taxonomy
- Federal specialty code 207WX0200X (207WX0200X); Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 3017 Telegraph Ave Ste 210, Berkeley, CA, 94705
- NPI first listed
- 2009-07-06
- NPI last updated
- 2024-10-01
- NPI record certified
- 2024-10-01
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Palo Alto, CA, 94304
This office lists an electronic records connection.